Related references
Note: Only part of the references are listed.Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study
Tasuku Harada et al.
FERTILITY AND STERILITY (2022)
Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy
Ayman Al-Hendy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists
Jacques Donnez et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest
Takashi Matsushima et al.
GYNECOLOGICAL ENDOCRINOLOGY (2020)
Classification and Reporting Systems for Adenomyosis
Malcolm G. Munro
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2020)
Long-term use of dienogest for the treatment of primary and secondary dysmenorrhea
Yutaka Osuga et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2020)
Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis
Olivier Donnez et al.
FERTILITY AND STERILITY (2020)
Endometriosis and nuclear receptors
Bahar D. Yilmaz et al.
HUMAN REPRODUCTION UPDATE (2019)
Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas A Randomized Controlled Trial
Yutaka Osuga et al.
OBSTETRICS AND GYNECOLOGY (2019)
Role of medical therapy in the management of uterine adenomyosis
Silvia Vannuccini et al.
FERTILITY AND STERILITY (2018)
Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis
Marc Bazot et al.
FERTILITY AND STERILITY (2018)
Pathogenesis of uterine adenomyosis: invagination or metaplasia?
Javier Garcia-Solares et al.
FERTILITY AND STERILITY (2018)
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
H. S. Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Pathogenesis of adenomyosis: an update on molecular mechanisms
Silvia Vannuccini et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2017)
Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial
Muhammad Fawzy et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2015)
Is adenomyosis associated with menorrhagia?
J. Naftalin et al.
HUMAN REPRODUCTION (2014)
Uterine Fibroids
Serdar E. Bulun
NEW ENGLAND JOURNAL OF MEDICINE (2013)
How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic
J. Naftalin et al.
HUMAN REPRODUCTION (2012)
Understanding adenomyosis: a case control study
F. Andrei Taran et al.
FERTILITY AND STERILITY (2010)
Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy
Khaleque Newaz Khan et al.
HUMAN REPRODUCTION (2010)
Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma
Khaleque Newaz Khan et al.
HUMAN REPRODUCTION (2010)
Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists
Mohamed A. Bedaiwy et al.
FERTILITY AND STERILITY (2009)
Progesterone resistance in endometriosis: Link to failure to metabolize estradiol
SE Bulun et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Share Paper
